연구성과로 돌아가기
2021 연구성과별 연구자 정보 (1353 / 2991)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Tse, William | Tse, W | 12 | Univ Louisville, Sch Med, Louisville, KY 40292 USA | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Sohn, Sang Kyun | Sohn, SK | 13 | Kyungpook Natl Univ Hosp, Daegu, South Korea | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Hiwase, Devendra | Hiwase, D | 14 | Royal Adelaide Hosp, Adelaide, SA, Australia | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Chevassut, Timothy | Chevassut, T | 15 | Brighton & Sussex Med Sch, Brighton, E Sussex, England | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Pierdomenico, Francesca | Pierdomenico, F | 16 | Portuguese Inst Oncol Lisbon, Lisbon, Portugal | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | La Torre, Ignazia | La Torre, I | 17 | Celgene Bristol Myers Squibb Co, Boudry, Switzerland | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Skikne, Barry | Skikne, B | 18 | Univ Kansas, Med Ctr, Kansas City, KS 66103 USA | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Skikne, Barry | Skikne, B | 18 | Bristol Myers Squibb, Princeton, NJ USA | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Bailey, Rochelle | Bailey, R | 19 | Bristol Myers Squibb, Princeton, NJ USA | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Zhong, Jianhua | Zhong, JH | 20 | Bristol Myers Squibb, Princeton, NJ USA | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Beach, C. L. | Beach, CL | 21 | Bristol Myers Squibb, Princeton, NJ USA | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Dombret, Herve | Dombret, H | 22 | Hop St Louis, Assistance Publ Hop Paris AP HP, Paris, France | fravandi@mdanderson.org; | |||||
| Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial | Dombret, Herve | Dombret, H | 22 | Univ Paris, Inst Rech St Louis, Paris, France | fravandi@mdanderson.org; | |||||
| Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic | Lee, Yu Rim | Lee, YR | 1 | 교신저자 | Kyungpook Natl Univ, Sch Med, Dept Internal Med, Daegu, South Korea | deblue00@naver.com; | ||||
| Management of perioperative acute massive pulmonary embolism: A case series | Kim, Ji-Yoon | Kim, JY | 1 | Kyungpook Natl Univ, Med Ctr, Sch Med, Dept Anesthesiol & Pain Med, Daegu, South Korea | ilwooshin@hanmail.net; |
페이지 이동: